Daicel Corporation

4202.T
Specialty Chemicals
2026/08/03 Updated
Market Cap: $2.3B (¥370.4B)
Stock Price: $9.18 (¥1,451)
Exchange Rate: 1 USD = ¥157.98

Stock Price Chart

2026/08/03 Updated
37.45
PER (Price Earnings Ratio)
vs Industry Avg: +27.9
1.04
PBR (Price to Book Ratio)
vs Industry Avg: -0.2
4.83%
Dividend Yield
vs Industry Avg: +1.88%

Price Trend

2026/08/03 Updated
Short-term
5-Day MA
-0.51%
Near-term
25-Day MA
+1.30%
Mid-term
75-Day MA
+9.99%
Long-term
200-Day MA
+7.77%

Price & Trading Details

2026/08/03 Updated

PRICE

Previous Close ¥1,446
Open ¥1,460
High ¥1,521
Low ¥1,414
Close ¥1,451

TRADING

Volume 3,849,500
Average Volume 1,624,596
Turnover ¥56億
Min. Purchase ¥145,050

Analyst Recommendations 8 analysts

Updated 2026/08/01
Strong Buy
0
Buy
2
2
Hold
4
4
Sell
1
1
Strong Sell
1
1
Target Price (Mean)
¥1,486
Hold
¥2,400
High
¥1,335
Median
¥1,260
Low
+6% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Earnings Calendar

Updated 2026/08/01

Recent Earnings

Date EPS Est. EPS Actual Surprise
2026/07/30 ¥22.29 ¥36.65 +64.4%
2026/05/12 ¥36.95 ¥-96.24 -360.5%
2026/02/04 ¥40.17 ¥64.09 +59.6%
2025/11/05 ¥57.20 ¥34.61 -39.5%

Shareholder Composition

Updated 2026/08/01
10.5%
Insider Holdings
54.5%
Institutional
35.1%
Public Float
115
Institutional Holders
Insider Holdings 10.5%
Institutional 54.5%
Public Float 35.1%

Major Holders

Updated 2026/08/01
Institution Ownership Shares Change
American Century ETF Trust-Avantis International Small Cap Value ETF
1.92%
4.9M +3.14%
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.36%
3.5M -2.98%
T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Discovery Fd.
1.21%
3.1M +13.86%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.87%
2.2M -0.75%
iShares Trust-iShares Core MSCI EAFE ETF
0.69%
1.8M 0.00%
Victory Portfolios-Victory Trivalent International Small-Cap Fund
0.65%
1.7M -0.04%

Dividend History

Updated 2026/08/02
-%
Dividend Yield
¥30
Annual Dividend
-50.0%
YoY Growth
77.4%
Payout Ratio
Year Dividend Change
2026 ¥30 -50.0%
2025 ¥60 +9.1%
2024 ¥55 +22.2%
2023 ¥45 +25.0%
2022 ¥36 -

Financial Performance

2026/08/02 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥467,937M ¥538,026M ¥558,056M ¥586,531M
Gross Profit ¥138,607M ¥145,811M ¥159,280M ¥164,746M
Operating Income ¥50,697M ¥47,508M ¥62,393M ¥61,011M
Pretax Income ¥47,644M ¥56,399M ¥77,698M ¥67,480M
Net Income ¥31,254M ¥40,682M ¥55,834M ¥49,480M
EPS ¥104.14 ¥138.87 ¥138.87 ¥181.44
Operating Margin 10.83% 8.83% 11.18% 10.40%
Balance Sheet
Total Assets ¥698,836M ¥765,606M ¥839,169M ¥813,831M
Total Equity ¥272,016M ¥295,208M ¥359,443M ¥359,983M
Total Liabilities ¥426,820M ¥470,398M ¥479,726M ¥453,848M
Cash ¥88,130M ¥93,840M ¥73,183M ¥65,142M
Interest-bearing Debt ¥280,502M ¥317,832M ¥299,790M ¥280,919M
Equity Ratio 38.92% 38.56% 42.83% 44.23%
D/E Ratio 1.03 1.08 0.83 0.78
Cash Flow
Operating CF ¥42,993M ¥26,847M ¥76,729M ¥93,406M
Investing CF -¥46,528M -¥44,093M -¥55,374M -¥47,869M
Financing CF -¥5,452M ¥19,956M -¥52,373M -¥48,855M
Free CF -¥4,478M -¥25,076M ¥7,521M ¥21,064M
Efficiency
ROE 11.49% 13.78% 15.53% 13.75%
ROA 4.47% 5.31% 6.65% 6.08%

Latest IR Information

Company Information

English Name Daicel Corporation
Japanese Name (株)ダイセル
Stock Code 4202.T (JPX)
Sector / Industry Basic Materials / Specialty Chemicals
Employees 11,034

About

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services. It also provides performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photoresists, optical lenses, and caprolactone derivatives; functional films and materials used in smartphones, PCs, TVs, and in-vehicle displays, polymers and solvents used in the semiconductor manufacturing process; and lenses used in VR, smartphones and various sensors. In addition, the company offers airbags inflators, pyro-fuses, and gas generators for seat belt pretensioners; acetic acid, acetic acid derivatives, acetate tow, ketene / diketene derivatives, cellulose acetate for LCD optical films, amines, and 1,3-butylene glycol; and reverse osmosis membrane and ultrafiltration membrane products, as well as water treatment systems. Further, it provides Engineering plastics comprising polyacetal, PBT resin, polybutylene terephthalate, polyphenylene sulfide, liquid crystal polymer, and cyclic olefin copolymer; AS resin, acetate plastics, water-soluble polymers, and barrier films for packaging; ABS resins, various polymer alloys, plastic compounds; Polyamide-12 and PEEK resin; and various molded containers. The company's products are used in transportation, electronics, medical care, personal care, lifestyle, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and is headquartered in Osaka, Japan.

Data provided by Yahoo Finance